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Abstract
Background: Smokers with chronic obstructive pulmonary disease (COPD) seem to be a special subgroup of smokers
that have a more urgent need to quit smoking but might find it more difficult to do so. This study aimed to explore
which justifications for tobacco smoking and experiences of quitting were commonly shared in smokers with and
without COPD, and which, if any, were specific to smokers with COPD.
Methods: In ten primary healthcare centres in the Netherlands, we conducted semi-structured, in-depth interviews in
10 smokers with and 10 smokers without COPD.
Results: Three themes were generated: ‘balancing the impact on health of smoking’, ‘challenging of autonomy by
social interference’, ‘prerequisites for quitting’. All participants trivialized health consequences of smoking; those with
COPD seemed to be less knowledgeable about smoking and health. Both groups of smokers found autonomy very
important. Smokers with COPD were indignant about a perceived lack of empathy in their communication with doctors.
Furthermore, smokers with COPD in particular had little faith in the efficacy of smoking cessation aids. Lastly, motivation
for quitting was dominated by fluctuation and smokers with COPD specifically maintained that their vision of life was
linked with quitting.
Conclusions: The participants showed many similarities in their reasoning about smoking and quitting.
The corresponding themes argue for a less paternalistic regime in the communication with smokers with
attention required for the motivational stage and room made for smokers’ own views, and with clear
information and education. Furthermore, addressing social interactions, health perceptions and moral
agendas in the communication with smokers with COPD may help to make smoking cessation interventions
more suitable for them.
Background
Chronic obstructive pulmonary disease (COPD) holds a
leading position in morbidity and mortality worldwide
[1]. In the Netherlands, approximately 320,000 people
have COPD. Approximately 6000 people died in 2010 in
the Netherlands with COPD as the primary cause [2].
Tobacco smoking is the most commonly encountered
risk factor for COPD in developed countries [1, 3, 4]. An
estimated 10 to 15 % of all smokers develop clinically
significant airflow obstruction [5]. Furthermore, smokers
with COPD have a higher mortality rate [1] and a more
rapid decline in lung function than non-smokers with
COPD [6]. Smoking cessation is the only evidence-based
intervention which has been proven to slow down the
accelerated decline in lung function in smokers with
COPD [1]. Several evidence-based smoking cessation in-
terventions are available but not yet widely used [7–10].
A systematic review has shown that smoking cessation
support in smokers with COPD is best when a combin-
ation of psychological and pharmacological interventions
is used [11].
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The majority of smokers know that smoking is harm-
ful to their health; and it is estimated that 50 % of
smokers with COPD are amenable to smoking cessation
support [12]. However, results from smoking cessation
intervention studies comparing smokers with and with-
out COPD have yielded ambiguous results. Higher, equal
and lower smoking cessation rates in smokers with
COPD were found compared to smokers without COPD
[13–16]. Nevertheless, the prevalence of smoking in
patients with COPD is still high and exceeds the rate of
smoking in the general population [17]. A large population-
based study showed that the prevalence of smoking cur-
rently was 35 % among patients with COPD compared with
22 % among patients without COPD [17]. This implies that
when patients get a diagnosis of COPD many still continue
smoking even though quitting is their best treatment
option. Their chances of quitting might partly be reduced
because of a higher level of tobacco addiction and suscepti-
bility to develop depressive symptoms [18, 19]. Therefore,
smokers with COPD seem to be a special subgroup of
smokers that have a more urgent need to quit smoking, but
might find it more difficult to do so [18].
A specific approach for smokers with COPD, while
probably needed, does not yet exist. In order to create
smoking cessation programs tailored to the needs of
smokers with COPD, we need to gain their own views
on smoking and quitting. Up until now, there have been
some qualitative studies reporting perspectives of smokers
with COPD [20–23]. Few of them have been able to iden-
tify concrete clinical implications. For example, Eklund et
al. described how important it is to make sure that the
smoker has the right intrinsic motivation before starting
an attempt to quit [22]. In addition, Wilson et al. pointed
out the importance of taking into account volatility in
patients’ decision making and formulating realistic goals
[21]. However, these studies only reported results of
smokers with COPD, making it unclear whether these
statements apply only to these smokers or are a reflection
of smokers in general. As far as we are aware, there are
only two studies comparing smokers with and without
COPD [24, 25]. These showed a lot of similarities between
the two groups [24, 25], but also some differences; smokers
with COPD had higher tobacco consumption, higher nico-
tine dependence and a different pattern of smoking com-
pared with smokers without COPD [24]. However, in these
studies there is no qualitative data on smokers’ specific
experiences regarding smoking cessation.
The aim of this qualitative study was to explore which
justifications for tobacco smoking and experiences of quit-
ting were commonly shared in smokers with and without
COPD, and which, if any, were specific to smokers with
COPD. Once researchers and healthcare providers under-
stand the concerns of smokers with COPD regarding quit-
ting and utilizing cessation treatments, they may address
these problems in customised smoking cessation interven-
tions in order to increase smoking cessation in smokers
with COPD.
Methods
Setting and study population
Participants for the interviews were derived from a cross-
sectional survey focusing on factors associated with smok-
ing cessation in smokers with and without COPD [19].
Participants were recruited from the ‘Eindhoven Corpor-
ation of Primary Healthcare centres’ (SGE), which is a
network of ten primary healthcare centres in the city of
Eindhoven, the Netherlands, covering approximately
65,000 patients [26].
In January 2012, all patients from SGE with a recorded
diagnosis of COPD (N = 1248) in their electronic med-
ical record (EMR) and twice as many patients without
COPD (N = 2466) received a questionnaire per postal
mail and an enclosed form on which they could indicate
if they were willing to participate in an interview. A total
of 437 patients (31 %) with COPD and 875 patients
(31 %) without COPD responded to the questionnaire.
Among these, we identified 107 current smokers with
COPD (24.5 % of 437) and 86 current smokers without
COPD (9.8 % of 875). Thirty-four percent (36/107) of the
patients with COPD and 53 % (46/86) of the patients
without COPD met the inclusion criteria for attendance at
the interview: willing to participate and being a current
smoker with a smoking history of at least five years. We
obtained written informed consent from all participants.
To provide elaborate understanding of smoking behav-
iour and smoking cessation, and supplement the cross-
sectional survey, a purposive sample of 10 smokers with
and 10 smokers without COPD was chosen by the
coordinating researcher (EE) for interviewing. They were
selected in order to include maximum variation in age
and sex within both groups. Furthermore, age and sex,
important risk factors for the development of COPD,
were equally distributed between both groups.
Data collection
Semi-structured in depth interviews of 60-90 min were
conducted. An interview topic guide, consisting of four
central topics, was developed, based on the literature
and expertise in the research team [see Additional file 1]
with the purpose of getting knowledge of the informants’
smoking narratives.
The interviews were performed in the participants’
homes to enable them to feel at ease and be open about
their reflections on smoking. Furthermore, the inter-
viewer attempted to adopt a non-judgmental attitude
and bridle presumptions and prejudices to assure room
for participants to express their thoughts freely on
smoking and smoking cessation. The interviews were
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audio recorded. Furthermore, the interviewer (EE) wrote
down non-verbal impressions and other notable infor-
mation. Transcription was done by one researcher (EE).
Participants were given a €15 gift voucher after the
interview was completed. The study was approved by
the Medical Ethics Committee of Maastricht University,
the Netherlands (approval number 11-4-145).
Analysis
The topic of smoking and smoking cessation is, in most
contexts, morally contentious. Attention must be paid to
the questions posed by the interviewer and responses
made by the interviewee, to avoid eliciting justifications
or normative, ideal statements only. We believe that
through a careful interview relationship we achieved
data both consisting of justifications, explanations and
patient-near experiences, reflecting what made sense to
the participants as immediate concerns and thoughts.
Still, in the analysis we paid attention to the moral con-
text of the data and attempted not to infer what could
not be justified.
Thematic analysis was used according to Braun and
Clarke [27]. EE orthographically transcribed the inter-
views and imported them into NVivo 9 [27]. Data collec-
tion and analysis were carried out concurrently by one
researcher (EE). EE checked the transcripts against the
original audio recordings for accuracy. Next, EE identi-
fied initial codes and formulated these in English. A
semantic approach was used which identified both the
explicit and surface meaning units as well as reflected
the smokers’ reality [27]. Primarily, we used an inductive
thematic analysis, which means that EE coded the text
without initially relating it to the aim of the study. The
researchers, however, did have a certain interest in
specific components regarding smoking cessation [27].
We realized a balance by giving some direction to the
information-collection process (topic list) whilst also
enabling different matters to evolve through the coding
process. EE and DK checked the English codes back
against the underlying Dutch quotes. Codes were then
discussed in detail and sorted into categories and subcat-
egories (EE and MBR). For example, there were categor-
ies titled ‘experiences of not being able to quit’ and
‘beliefs about the relationship between health and smok-
ing’, with subcategories describing different experiences
and beliefs the participants came up with. Next, the es-
sential contents of the codes were interpreted into
themes (EE and MBR). For example, the essence of all
the codes describing thoughts about health and smoking
resulted in the theme ‘balancing the impact on health of
smoking’. EE checked if the resulting thematic map
accurately reflected the meaning units evident in the
dataset as a whole [27]. EE discussed the resulting the-
matic map with MBR and DK. Afterwards we checked if
the themes and underlying codes contained differences
between smokers with and without COPD.
Overall, we used a constant comparative approach to
the data analysis with the aim to saturate the coded cat-
egories and themes. There was no need to extend the
data collection to more than twenty participants, since
the analysis made clear that the developing themes could
be filled in and enriched from the data we had.
Results
Characteristics of participants are displayed in Table 1.
All smokers had started smoking at a time when this
was socially acceptable. Most had started smoking be-
cause of social reasons.
Theme 1: Balancing the impact on health of smoking
The participants weighted and interpreted facts on the
relationship between smoking and health, and created
their own judgements and justifications about the health
risks of smoking. We noticed, for example, that some of
them were balancing the health risks of smoking against
the health risks of other addictive behaviours, such as
eating too much.
…and if I can’t smoke then I’ll spend all day eating!
What, then, is better for me? Because that way means
you’ll end up far too fat. [interview 6 – without
COPD]
Moreover, participants compared the impact on
health of smoking with the impact on health of air pol-
lution created by traffic and factories. They emphasized
that air pollution is as bad or even worse for their
health as smoking.
Living here on the Kennedylaan with the balcony
doors open, drinking a cup of coffee in the morning
sun – that’s much worse for you than smoking two
packs of roll-up tobacco a day. Those cars that drive
past and stop here for the traffic lights – now that’s
real filth! [interview 4 – without COPD]
Examples such as these suggested that the participants
did realize that smoking is bad for their health, because
they compared it with something else which is unhealthy
and stated that smoking is less bad. However, by talking
about other people and other pollution mechanisms
than their own smoking behaviour, they trivialized the
health consequences of their own smoking behaviour. In
other words, drawing on experiences and knowledge
sources seemed to create a practical reasoning to justify
their smoking behaviour.
Furthermore, the participants expressed inconsistent
views about the causal relationship between smoking
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and disease. At the beginning of the interview, many
participants in both groups said that they knew smoking
is bad for their health. However, all through the inter-
view, particular smokers with COPD would refine on
their previous statement. Moreover, there were smokers
with COPD who said they were unsure about the rela-
tion between smoking and having COPD.
…now if smoking really is the cause of that COPD, I
am not sure; I don’t know. I have no real idea where it
comes from. [interview 9 – with COPD]
Overall, participants did not differ much in their
expressions on the causal relationship between smoking
and disease. However, smokers with COPD did not ex-
press more awareness after having had the diagnosis and
some smokers with COPD even remarked, possibly as
justification or as fact, that the doctors had never told
them smoking was bad for their respiratory health.
Finally, existential reflections played a part in reason-
ing about smoking and health. Smokers with COPD par-
ticularly expressed that how they envisioned life and
death was interrelated with quitting.
…a while ago, I had a massive fear of death and that’s
the time that I had a total change of heart. I don’t
fear it at all anymore. That’s one of the reasons why I
ask myself why should I go without that cigarette
that I like so much? Why deprive myself? [interview
18 – with COPD]
Other smokers with COPD expressed similar feelings,
reasoning that they did not mind dying, therefore giving
up smoking was not relevant. One smoker with COPD
argued that by continuing with smoking at least he knew
what he would die of. As some of them had a particular
fear of pining away [waste away in misery] if they were
to quit smoking, they envisaged this not happening if
they continued smoking. There was also one smoker
without COPD who expressed such existential reflec-
tions. He had had an experience with a life-threatening
disease, which made him realize that, in contrast with
the smokers with COPD, he did not wish to die yet. In
conclusion, smokers with COPD seemed to justify the
fact that they were still smoking by existential reasoning;
there was no need for them to quit because they did not
mind dying from smoking. Conversely, the one smoker
without COPD seemed interested to quit due to existen-
tial reasoning; he realized he did not want to die and this
encouraged him to undertake a quit attempt.
Theme 2: Challenging of autonomy by social interference
The impact of comments or advice from different sources,
such as government, healthcare providers and family,
seemed to interfere greatly with the smokers’ feelings and
thoughts about smoking. Most comments in this regard
had a negative weighting. The participants said that, in
general people’s comments on smoking were experienced
as being meddlesome. They frequently described feeling
irritated, especially by ex-smokers’ comments.
Sometimes I reckon it’s exaggerated. Then I think, oh,
come on, guys, please! Those who used to smoke the
most have now stopped or are stopping, and they are
the ones with the most to say when anyone else is
smoking. [interview 2 – with COPD]
These feelings of irritation may be connected with a
strong feeling of autonomy. All participants felt they
needed freedom to decide to do as they wished. Further-
more, they felt they understood why general practi-
tioners (GP) advised them to stop smoking. However,
the participants mentioned in passing that they were
irritated by smoking cessation advice, especially when it
was very insistent: most of them would thus cut short
conversations about smoking.
I just don’t say anything, I refuse to discuss the
matter. It’s bad; I know that. I refuse to discuss it
because you end up in an argument that leads
Table 1 Characteristics of smokers with and without chronic





Female sex 40 (4) 40 (4)
Age, mean (SD) 60.0 (8.1) 62.6 (9.0)
Socioeconomic status [39]
Low 22 (2) 0
Moderate 68 (6) 60 (6)
High 11 (1) 40 (4)
GOLDa status (self-reported)
Mild 33 (3) n/a
Moderate 22 (2) n/a
Severe 11 (1) n/a
Very severe 0 n/a
I do not know 22 (2) n/a
Level of nicotine addiction [40]
Low 33 (3) 40 (4)
Medium 67 (6) 50 (5)
High 0 10 (1)
Motivation to quitb [41], mean (SD) 2.4 (1.3) 3.2 (1.9)
Data are presented as % (n) unless stated otherwise. Discrepancies between
total numbers and numbers of added subcategories are due to missing values
aGOLD = Global Initiative for Chronic Obstructive Lung Disease
b1-7 = highest level of motivation
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nowhere: he [GP] makes all sorts of remarks such as,
“It is really bad,” and then I say, “Yes, I know, but I
am going to carry on doing it [smoking] anyway.”
[interview 17 – without COPD]
Most of the participants had an opinion about
continuing smoking and seemed not to be susceptible
to external influences, such as advice from a GP. In
addition, smokers did not feel like actively responding
to the GP’s advice because they said they would sort it
out themselves. Again, feelings of autonomy domi-
nated. Furthermore, some smokers with COPD were
indignant about the communication with specialists
and GPs. This indignation seemed to be related to the
amount and type of emotional attention given by the
healthcare provider.
Personally, I think that the doctors of today are
rather lax. You are left to scrabble after everything
for yourself. There’s no real expression of
sympathetic interest in retrospect on their part.
[interview 9 – with COPD]
Smokers with COPD were indignant because they
felt that, these days, healthcare providers did not show
interest in them anymore. As one of the smokers with
COPD justified: if doctors had more empathy for
them, pieces of advice and comments on smoking and
smoking cessation would stick in their memory better
and would have a more encouraging effect. This might
seem to be a justification only, but this also reflects
the importance for doctors to build up solid relation-
ships with their patients in order to gain trust. This
trust is of particular importance for being able to dis-
cuss confidential and morally contentious topics, such
as smoking. Finally, governmental regulations were
not found to be motivating for quitting smoking
according to all participants. Even though they had
resigned themselves to the anti-smoking policies, they
considered them to be ineffective, discriminating and
out of proportion.
Theme 3: Prerequisites for quitting
The overall experience with regard to ‘quitting’, was pre-
sented in rather negative terms; it was about not being
able to quit. The participants often stated it was very
difficult to quit and that they had little faith that they
would be able to do so.
…and every time I decide to stop…for one reason or
another, I just can’t manage…I really do want to and
my wife does as well but that little bit of…will
power…that is what’s lacking. [interview 3 – with
COPD]
In addition, many smokers found a wide variety of pre-
conditions that had to be fulfilled before they would be
ready to make an attempt to quit. These preconditions,
however, were susceptible to changes.
I did have something once…it was last year. It was my
voice; it disappeared. Yes. Then I had to go to the
Ear, Nose and Throat specialist and he told me that
I had cancer of the vocal cords. And still I thought
to myself, “Now, listen; if they were able to remove
it then, then they can do the same next time.” So
that’s why I started smoking again. [interview 9 –
with COPD]
Furthermore, some of these conditions were not tan-
gible, which made it difficult for outsiders to understand
these conditions.
I say, “Yes, if a switch is flicked here [points at her
head], then I’ll quit”. [interview 2 – with COPD]
A lot of participants reasoned that if they really
wanted to quit, they could do it. They described this
motivation as a feeling from inside. One of the partici-
pants illustrated this by saying ‘it’s all in the mind’. Many
of these examples relate to intrinsic motivation to quit
smoking. Most of the participants had changeable expla-
nations and justifications concerning their willingness to
quit. They seemed to lack intrinsic motivation and had
difficulties obtaining it. However, they could give exam-
ples of extrinsic motivators such as health education or
comments from significant others, but these were mostly
only potential motivators, and might interfere with feel-
ings of autonomy (theme 2). We did not find examples
showing that in the end they actually persuaded them to
quit. In addition, some motivators, such as health com-
plaints, would disappear over time and therefore not
stimulate long-term abstinence. When these health
problems faded away, smoking again would easily start.
Furthermore, participants often said that life-events
interfered with their motivation to quit and with the
maintenance of an attempt to quit. Life-events would
prevent them from starting an attempt to quit and also
from maintaining the effort.
Finally, the availability of various smoking cessation
aids was not motivating for quitting either and smokers
with COPD in particular expressed that using smoking
cessation aids would only make sense and be effective if
one were ‘ready’ to quit. Nicotine replacement therapies
were not found to be effective by all participants be-
cause, afterwards, it was claimed that they did not work
or had a dirty taste or, beforehand, it was thought that
they did not stop the craving which was seen to be the
main difficulty in smoking cessation. The participants
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reported diverse views on medication, such as bupropion
and varenicline. However, smokers with COPD were
more negative about these medications. Finally, all par-
ticipants were sceptical about the use of e-cigarettes.
Some stated that by using them it made them smoke
more and they would not solve the craving problem.
Those who were somewhat positive about e-cigarettes
did not use them as an aid to quit but as a temporary
alternative. In general, smokers wanted aids to solve
their craving to smoke and fully to replace the effect
of a cigarette.
Discussion
All participants reported a lot of shared justifications
concerning smoking and experiences of quitting. They
all trivialized the health consequences of smoking and
also felt a threat of social interference in their autonomy
which did not motivate them to quit. However, smokers
with COPD seemed less knowledgeable about the rela-
tionship between their health and smoking; were indig-
nant about a perceived lack of empathy from doctors;
expressed in particular that their view of life was interre-
lated with quitting; and had less faith in the efficacy of
smoking cessation medications.
It became apparent from the interviews that smokers
generally trivialized the health consequences of smoking.
However, most of the smokers did make comments that
showed at least some consciousness of this relationship.
It is possible that answers on this topic from smokers in
general, and smokers with COPD in particular, reflect a
construction of justification of smoking as a certain style
of reasoning. However, we also argue that this is also
what made sense to their situation and lived experience
of being a smoker, the performance and embodiment of
a distinct health and risk discourse. Another aspect is
that answers on this topic in general might be biased by
optimism in order to reduce the psychological need to
quit smoking. This cognitive dissonance could be a cop-
ing mechanism to manage their lifestyle [28]. In general,
trivializing, comparing and, in that way, balancing differ-
ent knowledge sources are ingredients often involved in
creating and justifying a certain lifestyle [29, 30].
Autonomy was another key issue for smokers. It
seemed that advice and comments were mostly experi-
enced as being meddlesome, even when well-intended.
This made it challenging for healthcare providers to win
acceptance to discuss smoking and quitting. In the
Netherlands, individualism is highly valued, as in other
western European countries where qualitative research
on smokers with COPD has found that these smokers
had a great need for autonomy, and decisions had to be
taken independently in order to retain that autonomy
[22]. In that study, smokers with COPD sympathized
with the idea of receiving help and support, but without
being patronized [22]. The same need for supportive
emotional communication was seen in our smokers with
COPD, who found that doctors lacked empathy for, and
interest in, their patients.
We found that motivation for quitting was volatile and
sometimes intangible, both in smokers with and without
COPD. In several behavioural change models, motiv-
ation is one of the key elements to explain changes in
health behaviour [31–33]. In previous research, smokers
with COPD have acknowledged the need for intrinsic
motivation and will power to stop smoking, but they
were unsure about how to obtain and maintain will
power [21]. Similarly, in our study, motivation for quit-
ting was often referred to as ‘something from inside’
which was not tangible and smokers were unsure how to
achieve it. Nevertheless, smokers described intrinsic
motivation as the most important motivator for success-
ful quitting. In addition, extrinsic motivation can stimu-
late quitting as a result of an external source [21, 34]. In
our study, smokers did not seem to believe in the effi-
cacy of extrinsic motivators. Similar to the findings of
previous research, external sources were found to be
demotivating at times; life events often provided reasons
for never finding the time to focus on smoking cessation
[22]. In conclusion, motivating and demotivating factors
were volatile, which was also seen in previous research
on smokers with COPD [21].
Most smokers thought of smoking cessation aids as
being ineffective. Smokers with COPD in particular
stated that using smoking cessation aids would only
make sense and be effective if one were ‘ready’ to quit.
With these expressions they seemed to have little faith
in the efficacy of smoking cessation aids. A recent study
in the Netherlands showed that a low level of knowledge
about the evidence-base of aids was possibly due to the
promotion of ineffective commercial cessation methods
[35]. Furthermore, the lower socio-economic status in
the group of smokers with COPD might have been
negatively associated with their level of faith in smoking
cessation aids, as they are likely to be less educated,
hence more likely to dismiss or misunderstand the
evidence for smoking cessation aids. In addition, one
could also discuss the perception of when a treatment
is effective: smokers in our study often expressed that
smoking cessation aids were ineffective because they
did not make them quit smoking after their use.
Smokers with COPD in particular were negative about
the side effects and inefficacy of medication such as
bupropion and varenicline, both before and after they
had used them. This attitude might be counterproduct-
ive because smokers with COPD are more nicotine-
dependent [19, 24], which makes this evidence-based
medication of particular importance to this group of
smokers [36, 37].
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The study has strengths: the background and interview
training of the interviewer (EE) increased the quality of
the interviews. Participants were interviewed in their
own home for comfort which contributed to open con-
versations about a confidential and morally contentious
topic. During the interview EE tried not to be guided by
the knowledge of whether an interviewee was a smoker
with or without COPD and also coded both groups as a
whole in order to prevent guidance by potential differ-
ences. EE wrote down non-verbal impressions during
the interview and transcription: in this way, an analysis
of both verbal statements, non-verbal impressions and
contextual conditions for data production was realized.
In addition, researcher triangulation was used in order
to overcome intrinsic bias.
Some limitations also need to be mentioned: selection
bias might have occurred as the participants engaged in
the interviews could have held stronger views about
smoking and quitting than the ones that were not inter-
ested to participate. However, we still saw a diversity of
characteristics and opinions coming up, which may indi-
cate that the results reflect the views of the general
population of smokers. A pragmatic number of inter-
views was done initially, however we found that the ana-
lytic process made our arguments coherent, i.e. we
decided that no further interviews were necessary. The
generation of the initial codes was done by one re-
searcher (EE) only and MBR, who helped initiate the
codebook, was not able to read the interviews herself
because of a language mismatch. However, considerable
time was spent on discussion and explanation of the
contents of the interviews. The study’s generalizability
may be limited but is determined by its overall design.
However, we believe a thorough and consistent design as
well as analysis gives credibility to analytic generalisa-
tion, i.e. the development of valid, rich findings feeding
into a general understanding of a field of research which
we hope to have presented [38].
Conclusions
The participants showed many similarities in their rea-
soning about smoking and quitting. Both groups trivial-
ized the health consequences of smoking and had no
faith in the efficacy of smoking cessation aids. Further-
more, all participants reported fluctuation in motivation
to quit and the importance of autonomy in making their
own decisions. With regards to the smokers with COPD,
some specific remarks should be made: they seemed less
knowledgeable regarding the relation between their
health and smoking and had less faith in the efficacy of
medication. Besides, they expressed more existential
reflections on their smoking behaviour and were indig-
nant about the perceived lack of empathy from doctors.
For future smoking cessation interventions the corre-
sponding themes argue for a less paternalistic regime
when communicating with smokers. Smoker’s views
need to be explored, particularly regarding their motiv-
ation to quit. Clear information and education needs to be
provided on the efficacy of smoking cessation aids and the
negative consequences of smoking on health. In addition to
these general recommendations for smoking cessation
interventions, some recommendations for COPD tailored
smoking cessation interventions can be made: GPs should,
in their communication with smokers with COPD, take
more time to explore social interactions, health perceptions
and moral agendas that influence thoughts, feelings and
what makes sense concerning smoking and quitting. Once
the healthcare provider has gained a common under-
standing and trust, information and education about
the relationship between COPD and smoking, and the
use and efficacy of various smoking cessation aids, will
possibly be appreciated more and absorbed better by
the smokers with COPD.
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